Danielle M File

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer

C. Perou, L. Carey, A. Deal, 2022, Breast Cancer Research and Treatment.

Escalating and De-escalating Therapy for Early-Stage HER2-Positive Breast Cancer.

L. Carey, G. Curigliano, Danielle M File, 2020, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome

S. Khagi, Katherine P. Morgan, Danielle M. File, 2020, JCO precision oncology.

Can we predict the response to therapy in soft tissue sarcoma?

J. Grilley-Olson, Danielle M. File, Danielle M File, 2018, Future oncology.

Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series

Y. Whang, P. Googe, F. Collichio, 2019, Journal of Immunotherapy for Cancer.

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.

L. Carey, J. Frelinger, L. Bixby, 2023, Journal of immunology.